July 24, 2008 at 07:00 AM EDT
Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer

LEXINGTON, Mass., July 24 /PRNewswire/ -- Tepha, Inc., a developer of medical devices derived from a new class of resorbable polymers, announced today that it has appointed John Hartnett to the new position of Executive Vice President and Chief Operating Officer. Mr. Hartnett joins Tepha following an eighteen year career with Boston Scientific during which he progressed from field sales, to marketing management, and, most recently, to strategic planning and business development. Mr. Hartnett's responsibilities with Tepha will focus on corporate partner management and long range planning.

Dr. Simon Williams, President and CEO of Tepha, commented, "We are very excited to be able to attract an executive with John Hartnett's track record of success in the medical device industry. The unique profile of our resorbable polymer technology, combined with the receipt of six FDA 510(k)'s since February, 2007, has resulted in a significant increase in Tepha's corporate partner activities. Mr. Hartnett's strategic planning and business development experience will be extremely valuable as Tepha expands its corporate partnering business model."

About Tepha, Inc.

Tepha, Inc., is a developer of medical devices derived from a new class of resorbable polymers that have been engineered utilizing recombinant DNA technology. The unique biologic and mechanical properties of the Tepha PHA polymers has been recognized by an expanding list of corporate partners that now includes Aesculap AG, ENTrigue Surgical, HemCon Medical Technologies, the Lifecell subsidiary of Kinetic Concepts (NYSE: KCI), NMT Medical (Nasdaq: NMTI), and Tornier, Inc. Tepha received its first FDA 510(k) clearance for its TephaFLEX(R) Absorbable Suture in February, 2007 and the Company and its partners have now received six 510(k)'s covering a range of medical devices including sutures, meshes, and films.

For further information about Tepha, please contact Dr. Ajay Ahuja, M.D., Director of Business Development, Tepha, Inc., 99 Hayden Ave, Lexington, MA 02421, tel: 781-357-1700. Email: contact@tepha.com. Or visit: http://www.tepha.com

SOURCE Tepha, Inc.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here